Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Focus Areas
About Investor
Leen Kawas is the Managing General Partner at Propel Bio Partners, focusing on investments from $100K to $5.0M in medical devices, biotech, pharmaceuticals, consumer health, and health IT sectors at seed to Series B stages. She is based in Los Angeles, California. Her recent investment includes the biotech company Geneoscopy. Leen has a strong background in life sciences and healthcare venture capital, emphasizing transformative health technologies.
Similar Investors
Abdul Ly
Seed
,Series A
,Paul Straub
Pre Seed
,Seed
,Shaun Abrahamson
Pre Seed
,Seed
,Riley Florsheim
Pre Seed
,Seed
,Steve Brownlie
Pre Seed
,Seed
,Danielle Graham
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free